ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)

CUSIP: 02043Q107

Q4 2019 13F Holders as of 31 Dec 2019

Security identity 2 facts
Shares outstanding
133,131,695
Holder snapshot 9 facts
Share change
-2,234,778
Put/Call ratio
86%
Reported price per share
$115.17
Number of holders
306
Value change
-$233,499,979
Number of buys
154
Number of sells
124

Security key

02043Q107

Report period

Q4 2019

Institutions

306

Top holders

10

Ownership snapshot

Top reported holders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FMR LLC
13D/G signal
Evidence rows
15
Latest as of
30 Sep 2019
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Rank 1 holder

FMR LLC

13F
Ownership
13%
Position
$1.34B
13F
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
13%
$1,341,499,000
16,681,147 shares
30 Sep 2019
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
11%
$1,192,862,000
14,832,907 shares
30 Sep 2019
VANGUARD GROUP INC
13F
Company
13F
7.6%
$817,298,000
10,162,871 shares
30 Sep 2019
BAILLIE GIFFORD & CO
13F
Company
13F
6.2%
$662,336,000
8,235,974 shares
30 Sep 2019
BlackRock Finance, Inc.
13F
Company
13F
5.3%
$571,396,000
7,105,169 shares
30 Sep 2019
DODGE & COX
13F
Company
13F
4%
$427,175,000
5,311,801 shares
30 Sep 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
306
Shares
105,328,965
Rows available
306
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
276
Q4 2019 holders
306
Holder diff
30
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 value Q4 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .